Cargando…
Potential Role of Nanoparticles in Treating the Accumulation of Amyloid-Beta Peptide in Alzheimer’s Patients
The disorder of Alzheimer’s is marked by progressive pathophysiological neurodegeneration. The amino acid peptides in the amyloid plaques found in the brains of people with Alzheimer’s disease (AD) are known as amyloid-beta (Aβ). Current treatments are not curative, and the effects associated with A...
Autor principal: | Abbas, Mohamed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036916/ https://www.ncbi.nlm.nih.gov/pubmed/33801619 http://dx.doi.org/10.3390/polym13071051 |
Ejemplares similares
-
Islet amyloid polypeptide & amyloid beta peptide roles in Alzheimer’s disease: two triggers, one disease
por: Ferreira, Sofia, et al.
Publicado: (2020) -
Oxidative stress and the amyloid beta peptide in Alzheimer’s disease
por: Cheignon, C., et al.
Publicado: (2017) -
Amyloid-beta peptide and tau protein crosstalk in Alzheimer’s disease
por: Roda, Alejandro R., et al.
Publicado: (2022) -
“Amyloid‐beta accumulation cycle” as a prevention and/or therapy target for Alzheimer's disease
por: Rao, Chinthalapally V., et al.
Publicado: (2020) -
Accumulation of Innate Amyloid Beta Peptide in Glioblastoma Tumors
por: Kucheryavykh, Lilia Y., et al.
Publicado: (2019)